TNFRSF4 and cancer: Based on the fact that CD28-CAR-T cells are more potent in killing cancer cells, and 4-1BB-CAR-T cells exhibit lower depletion rates and longer-lasting killing effects on cancer cells (30), third-generation CARs added both CD28 and OX-40/4-1BB (31).